AstraZeneca vaccine: Careless talk has dented confidence and uptake in Europe
How one patient’s rare mutation helped solve a mycobacterial mystery
10 March 2021Pollen can raise your risk of getting COVID-19, whether you have allergies or not
10 March 2021AstraZeneca vaccine: Careless talk has dented confidence and uptake in Europe
At the start of the year, one of the main causes of the EU’s slow rollout of COVID-19 vaccines was lower than expected supplies from AstraZeneca. Fast forward a few weeks and the EU’s vaccination program still trails far behind the UK and US, but politicians and those in public health now have something else to worry about: low uptake of the AstraZeneca vaccine. In France, over three-quarters of AstraZeneca vaccines remain unused. In Germany, the figure is two-thirds.
